Autoimmune-associated thrombosis: mechanisms, population burden, and prevention strategies
Deepa J Arachchillage, Megan V Preece, Mike Laffan · 2026
Read Autoimmune-associated thrombosis: mechanisms, population burden, and prevention strategies by Deepa J Arachchillage, Megan V Preece, Mike Laffan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13571463.txt.
Description
Deepa Arachchillage, Megan Preece, and Mike Laffan review blood clotting driven by autoimmune disease, in a paper from 2026. Conditions like lupus and rheumatoid arthritis raise the risk of clots, heart disease, and early death. Some clotting disorders are autoimmune in their own right, triggered by drugs or vaccines. The review gathers the scale, causes, diagnosis, and care of this burden.
Clots form through many paths: antibodies that spark clotting, harmed vessel walls, and traps cast by immune cells. Classic risks like smoking and high blood pressure pile on top. Care blends blood thinners, immune-calming drugs, and risk control over years. The authors call the burden under-counted across Europe. They urge earlier spotting and joint care across specialties. Prevention plans for heart disease should fold these diseases in.
Catalog record
| CREATOR | Deepa J Arachchillage, Megan V Preece, Mike Laffan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |